Press releases

* (R) = Regulatory press releases

10 Oct, 2019

(R) Cantargia reports filing of opposition against Cantargia patent in Europe
04 Sep, 2019

(R) Cantargia submits request for pre-IND meeting on CAN04 with US FDA
23 Aug, 2019

(R) Cantargia announce positive preclinical data on CAN04 in bladder cancer
23 Aug, 2019

(R) Cantargia announce positive preclinical data on CAN04 in bladder cancer
23 Aug, 2019

(R) Cantargia and BioWa extend ongoing collaboration around the POTELLIGENT® Technology
22 Aug, 2019

(R) Cantargia publishes half year report
04 Jul, 2019

(R) Cantargia announce full recruitment of CAN04 monotherapy arm in ongoing phase IIa clinical trial
02 Jun, 2019

(R) Cantargia: presentation of phase I clinical data on antibody CAN04 at ASCO
27 May, 2019

(R) Annual General Meeting in Cantargia AB (publ)
27 May, 2019

(R) Cantargia publishes interim report for first quarter 2019
Older press releases >>

In media

Article about Cantargias antibody based cancer treatment with multiple functions 2019-10-31

Affärstidningen Näringsliv

Presentation at ASCO 2019, follow up articles and interviews - 2019-07-02

ASCO

Cantargia interview at EFN after ASCO - 2019-06-17

EFN

CEO interview, Edison, London - 2019-02-26

Edison TV

CEO interview, EFN, Lund (In Swedish) - 2018-11-22

EFN

Interview around CAN04 clinical results, Redeye, Stockholm (In Swedish) - 2018-10-23

Redeye

Listing ceremony for Cantargia on Nasdaq Stockholm Main Market - 2018-09-25

Nasdaq

CEO interview in connection with listing Nasdaq Stockholm (Small Cap), EFN, Stockholm (In Swedish) - 2018-09-25

EFN

CEO interview in connection with listing Nasdaq Stockholm (Small Cap), Ditv, Stockholm (In Swedish) - 2018-09-25

Di

CEO interview, Redeye, Stockholm (In Swedish) 2018-09-06

Redeye

CEO interview, BioStock Live, Stockholm (In Swedish) -2018-08-29

Direkt Studios

Småbolagspanelen: Om framtidens cancerbehandlingar, Småbolagsdagen, Stockholm (in Swedish) 2018-06-11

Aktiespararna

CEO interview BioStock Live, Stockholm (In Swedish) -2018-03-20

Direkt Studios

CEO-interview 2017-12-12

Aktiespararna

Interview with Cantargia's CEO Göran Forsberg after the presentation at BioStock Live i Stockholm - 2017-12-04

Direkt Studios

CEO-interview - 2017-11-29

Finwire.tv

Video, interview Göran Forsberg, President Cantargia, Sedermera-dagen, Lund - 2016-03-16

Finwire.tv

CONTACT US
Cantargia AB
Scheelevägen 27
SE-223 63 Lund, Sweden

E-mail: info@cantargia.com
Switch board: +46(0)46 2756260

Privacy Policy

Subscribe to our press releases

© Copyright 2019 · Cantargia AB